Clinical Trial Detail

NCT ID NCT02591654
Title MRI/PET Imaging to Assess Response to Pembrolizumab in Metastatic Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Columbia University
Indications

melanoma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.